首页 > 最新文献

Neurochirurgie最新文献

英文 中文
Impact of chronotherapy and time-of-day on surgical and adjuvant outcomes in glioblastoma and mixed high-grade glioma patients: a systematic review 时间疗法和时间对胶质母细胞瘤和混合高级别胶质瘤患者手术和辅助治疗结果的影响:一项系统综述。
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-04 DOI: 10.1016/j.neuchi.2026.101782
Siddharth Shah , Anuraag Punukollu , Brandon Lucke-Wold

Background

Circadian rhythms regulate DNA repair, cell-cycle progression, metabolism, and immune function processes central to glioblastoma (GBM) treatment response. Aligning therapy with intrinsic biological timing (“chronotherapy”) may improve efficacy without increasing toxicity. This systematic review evaluated the impact of treatment time-of-day on outcomes in GBM, focusing on temozolomide (TMZ) administration, radiotherapy (RT) scheduling, and surgical timing.

Methods

Following PRISMA 2020 guidelines, PubMed, Embase, and Google Scholar were searched through October 2025 for original human studies of adults with GBM or high-grade glioma comparing outcomes by time-of-day exposure (PROSPERO-CRD420251185806). Eligible endpoints included overall survival (OS), progression-free survival (PFS), postoperative complications, and length of stay (LOS). Randomized and observational studies were assessed using RoB 2 and ROBINS-I tools, respectively, and synthesized narratively due to heterogeneity.

Results

Six studies met inclusion criteria: three on TMZ timing, two on RT timing, and one on surgical timing. Morning TMZ was associated with longer OS in a retrospective cohort (median 1.43 vs 1.13 years; HR 0.67, 95% CI 0.46–0.98) and a similar trend in a feasibility trial (20.3 vs 16.4 months), though a large pooled analysis from two EORTC trials showed no OS/PFS difference but higher myelosuppression with morning dosing. Afternoon RT improved OS (25.6 vs 18.5 months, p = 0.014) and PFS (20.6 vs 13.3 months, p = 0.022) in a circadian-synchronized cohort, while other RT and surgical studies reported no time-dependent effects.

Conclusion

Available evidence suggests that treatment time-of-day may be associated with modest and context-dependent differences in adjuvant therapy outcomes in glioblastoma. Signals favoring morning temozolomide administration and afternoon radiotherapy are biologically plausible but inconsistent, while current data do not support a clinically meaningful effect of surgical timing. These findings should be considered hypothesis-generating, underscoring the need for prospective, biomarker-guided chronotherapy trials before clinical implementation.
背景:昼夜节律调节DNA修复,细胞周期进程,代谢和免疫功能过程对胶质母细胞瘤(GBM)治疗反应至关重要。调整治疗与内在生物时间(“时间疗法”)可以提高疗效而不增加毒性。本系统综述评估了治疗时间对GBM预后的影响,重点是替莫唑胺(TMZ)给药、放疗(RT)计划和手术时机。方法:根据PRISMA 2020指南,PubMed、Embase和谷歌Scholar检索了截至2025年10月的GBM或高级别胶质瘤成人的原始人类研究,比较了每天暴露时间的结果(PROSPERO-CRD420251185806)。符合条件的终点包括总生存期(OS)、无进展生存期(PFS)、术后并发症和住院时间(LOS)。随机和观察性研究分别使用RoB 2和ROBINS-I工具进行评估,并由于异质性而进行叙述性综合。结果:6项研究符合纳入标准:3项关于TMZ时机,2项关于RT时机,1项关于手术时机。在回顾性队列中,早晨TMZ与较长的OS相关(中位数1.43 vs 1.13年;HR 0.67, 95% CI 0.46-0.98),在可行性试验中也有类似的趋势(20.3 vs 16.4个月),尽管来自两项EORTC试验的大型汇总分析显示,早晨给药没有OS/PFS差异,但骨髓抑制较高。在一个昼夜同步的队列中,下午RT改善了OS(25.6个月vs 18.5个月,p = 0.014)和PFS(20.6个月vs 13.3个月,p = 0.022),而其他RT和手术研究报告没有时间依赖性的影响。结论:现有证据表明,治疗时间可能与胶质母细胞瘤辅助治疗结果的适度和环境依赖性差异有关。支持上午替莫唑胺给药和下午放疗的信号在生物学上是合理的,但不一致,而目前的数据不支持手术时间有临床意义的影响。这些发现应该被认为是假设的产生,强调在临床实施之前需要前瞻性的、生物标志物引导的时间疗法试验。
{"title":"Impact of chronotherapy and time-of-day on surgical and adjuvant outcomes in glioblastoma and mixed high-grade glioma patients: a systematic review","authors":"Siddharth Shah ,&nbsp;Anuraag Punukollu ,&nbsp;Brandon Lucke-Wold","doi":"10.1016/j.neuchi.2026.101782","DOIUrl":"10.1016/j.neuchi.2026.101782","url":null,"abstract":"<div><h3>Background</h3><div>Circadian rhythms regulate DNA repair, cell-cycle progression, metabolism, and immune function processes central to glioblastoma (GBM) treatment response. Aligning therapy with intrinsic biological timing (“chronotherapy”) may improve efficacy without increasing toxicity. This systematic review evaluated the impact of treatment time-of-day on outcomes in GBM, focusing on temozolomide (TMZ) administration, radiotherapy (RT) scheduling, and surgical timing.</div></div><div><h3>Methods</h3><div>Following PRISMA 2020 guidelines, PubMed, Embase, and Google Scholar were searched through October 2025 for original human studies of adults with GBM or high-grade glioma comparing outcomes by time-of-day exposure (PROSPERO-CRD420251185806). Eligible endpoints included overall survival (OS), progression-free survival (PFS), postoperative complications, and length of stay (LOS). Randomized and observational studies were assessed using RoB 2 and ROBINS-I tools, respectively, and synthesized narratively due to heterogeneity.</div></div><div><h3>Results</h3><div>Six studies met inclusion criteria: three on TMZ timing, two on RT timing, and one on surgical timing. Morning TMZ was associated with longer OS in a retrospective cohort (median 1.43 vs 1.13 years; HR 0.67, 95% CI 0.46–0.98) and a similar trend in a feasibility trial (20.3 vs 16.4 months), though a large pooled analysis from two EORTC trials showed no OS/PFS difference but higher myelosuppression with morning dosing. Afternoon RT improved OS (25.6 vs 18.5 months, <em>p</em> = 0.014) and PFS (20.6 vs 13.3 months, <em>p</em> = 0.022) in a circadian-synchronized cohort, while other RT and surgical studies reported no time-dependent effects.</div></div><div><h3>Conclusion</h3><div>Available evidence suggests that treatment time-of-day may be associated with modest and context-dependent differences in adjuvant therapy outcomes in glioblastoma. Signals favoring morning temozolomide administration and afternoon radiotherapy are biologically plausible but inconsistent, while current data do not support a clinically meaningful effect of surgical timing. These findings should be considered hypothesis-generating, underscoring the need for prospective, biomarker-guided chronotherapy trials before clinical implementation.</div></div>","PeriodicalId":51141,"journal":{"name":"Neurochirurgie","volume":"72 2","pages":"Article 101782"},"PeriodicalIF":1.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146133536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors and predictive model development for intracranial infection following surgical clipping of unruptured intracranial anterior circulation aneurysms 未破裂颅内前循环动脉瘤手术夹闭后颅内感染的危险因素及预测模型的发展。
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-19 DOI: 10.1016/j.neuchi.2026.101775
Kun Dai , Chengyuan Ji , Pengfei Xia, Youjia Qiu

Background

Postoperative intracranial infection (ICI) is a serious complication that occurs after craniotomy, typically caused by the invasion of microorganisms such as bacteria into the sterile cranial cavity. Aneurysm clipping is one of the primary treatment methods for intracranial aneurysms, and ICI can significantly impact patient prognosis. Our investigation aims to systematically identify the determinants of postoperative ICI after aneurysm clipping and develop a robust predictive model for clinical risk assessment. To eliminate potential confounding factors introduced by aneurysm rupture and subarachnoid hemorrhage, our study focuses exclusively on patients with unruptured intracranial anterior circulation aneurysms.

Methods

We conducted a retrospective analysis of clinical data from 428 patients with anterior circulation aneurysms. Based on the occurrence of postoperative ICI, patients were stratified into non-infected group and infected group. Univariate and multivariate statistical analyses were performed to evaluate the following variables: gender, age, body mass index (BMI), hypertension, diabetes mellitus, aneurysm location, number of aneurysm clips applied, operative duration, intraoperative blood loss, cerebrospinal fluid (CSF) leakage, and postoperative intracranial hemorrhage or cerebral infarction in the surgical region. Subsequently, a predictive nomogram was constructed based on the multivariate regression results to generate a robust predictive model.

Results

Among 428 patients with anterior circulation aneurysms, 38 developed postoperative ICI. Univariate analysis revealed that BMI, diabetes mellitus, operative duration, intraoperative blood loss, CSF leakage, and postoperative cerebral hemorrhage or infarction were significant factors influencing ICI. In contrast, variables such as gender, age, hypertension, and the number of aneurysm clips applied demonstrated no statistically significant association. Subsequent logistic regression analysis identified elevated BMI, diabetes mellitus, prolonged operative duration, substantial intraoperative blood loss, and postoperative CSF leakage as independent risk factors for ICI in UIA patients. A receiver operating characteristic (ROC) curve was constructed based on the predicted probabilities of ICI, yielding an area under the curve (AUC) of 0.8756, indicating strong predictive accuracy.

Conclusion

Postoperative ICI in patients with anterior circulation aneurysms is influenced by multiple factors, including BMI, diabetes mellitus, operative duration, intraoperative blood loss, and CSF leakage. A predictive model constructed based on the relative impact of these factors may assist clinicians in anticipating potential infection events during the perioperative period.
背景:术后颅内感染(ICI)是开颅术后发生的严重并发症,通常由细菌等微生物侵入无菌颅腔引起。动脉瘤夹闭术是颅内动脉瘤的主要治疗方法之一,而动脉瘤夹闭术对患者预后有显著影响。我们的研究旨在系统地确定动脉瘤夹闭术后ICI的决定因素,并为临床风险评估建立一个强大的预测模型。为了消除动脉瘤破裂和蛛网膜下腔出血带来的潜在混杂因素,我们的研究只关注未破裂的颅内前循环动脉瘤患者。方法:对428例前循环动脉瘤患者的临床资料进行回顾性分析。根据术后ICI的发生情况将患者分为未感染组和感染组。对性别、年龄、体重指数(BMI)、高血压、糖尿病、动脉瘤位置、动脉瘤夹置入次数、手术时间、术中出血量、脑脊液(CSF)漏出、术后手术区域颅内出血或脑梗死进行单因素和多因素统计分析。然后,基于多元回归结果构建预测模态图,生成稳健的预测模型。结果:428例前循环动脉瘤患者中,38例术后发生ICI。单因素分析显示,BMI、糖尿病、手术时间、术中出血量、脑脊液漏、术后脑出血或脑梗死是影响ICI的重要因素。相反,性别、年龄、高血压和动脉瘤夹的数量等变量没有统计学上的显著相关性。随后的logistic回归分析发现BMI升高、糖尿病、手术时间延长、术中大量失血和术后脑脊液漏是UIA患者发生ICI的独立危险因素。基于ICI的预测概率构建了受试者工作特征(ROC)曲线,曲线下面积(AUC)为0.8756,预测精度较高。结论:前循环动脉瘤患者术后ICI受BMI、糖尿病、手术时间、术中出血量、脑脊液漏等多种因素影响。基于这些因素的相对影响构建的预测模型可以帮助临床医生预测围手术期潜在的感染事件。
{"title":"Risk factors and predictive model development for intracranial infection following surgical clipping of unruptured intracranial anterior circulation aneurysms","authors":"Kun Dai ,&nbsp;Chengyuan Ji ,&nbsp;Pengfei Xia,&nbsp;Youjia Qiu","doi":"10.1016/j.neuchi.2026.101775","DOIUrl":"10.1016/j.neuchi.2026.101775","url":null,"abstract":"<div><h3>Background</h3><div>Postoperative intracranial infection (ICI) is a serious complication that occurs after craniotomy, typically caused by the invasion of microorganisms such as bacteria into the sterile cranial cavity. Aneurysm clipping is one of the primary treatment methods for intracranial aneurysms, and ICI can significantly impact patient prognosis. Our investigation aims to systematically identify the determinants of postoperative ICI after aneurysm clipping and develop a robust predictive model for clinical risk assessment. To eliminate potential confounding factors introduced by aneurysm rupture and subarachnoid hemorrhage, our study focuses exclusively on patients with unruptured intracranial anterior circulation aneurysms.</div></div><div><h3>Methods</h3><div>We conducted a retrospective analysis of clinical data from 428 patients with anterior circulation aneurysms. Based on the occurrence of postoperative ICI, patients were stratified into non-infected group and infected group. Univariate and multivariate statistical analyses were performed to evaluate the following variables: gender, age, body mass index (BMI), hypertension, diabetes mellitus, aneurysm location, number of aneurysm clips applied, operative duration, intraoperative blood loss, cerebrospinal fluid (CSF) leakage, and postoperative intracranial hemorrhage or cerebral infarction in the surgical region. Subsequently, a predictive nomogram was constructed based on the multivariate regression results to generate a robust predictive model.</div></div><div><h3>Results</h3><div>Among 428 patients with anterior circulation aneurysms, 38 developed postoperative ICI. Univariate analysis revealed that BMI, diabetes mellitus, operative duration, intraoperative blood loss, CSF leakage, and postoperative cerebral hemorrhage or infarction were significant factors influencing ICI. In contrast, variables such as gender, age, hypertension, and the number of aneurysm clips applied demonstrated no statistically significant association. Subsequent logistic regression analysis identified elevated BMI, diabetes mellitus, prolonged operative duration, substantial intraoperative blood loss, and postoperative CSF leakage as independent risk factors for ICI in UIA patients. A receiver operating characteristic (ROC) curve was constructed based on the predicted probabilities of ICI, yielding an area under the curve (AUC) of 0.8756, indicating strong predictive accuracy.</div></div><div><h3>Conclusion</h3><div>Postoperative ICI in patients with anterior circulation aneurysms is influenced by multiple factors, including BMI, diabetes mellitus, operative duration, intraoperative blood loss, and CSF leakage. A predictive model constructed based on the relative impact of these factors may assist clinicians in anticipating potential infection events during the perioperative period.</div></div>","PeriodicalId":51141,"journal":{"name":"Neurochirurgie","volume":"72 2","pages":"Article 101775"},"PeriodicalIF":1.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146013360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intraoperative contrast-enhanced ultrasound-assisted resection of brain tumors: a systematic review and meta-analysis 术中造影增强超声辅助脑肿瘤切除术:一项系统综述和荟萃分析
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-12 DOI: 10.1016/j.neuchi.2026.101774
Márcio Yuri Ferreira , Leonardo Januário Campos Cardoso , Shayan Huda , Netanel Ben-Shalom

Background

Given the critical importance of optimizing the extent of resection (EoR) in brain tumor surgery, intraoperative imaging techniques continue to evolve, enhancing tumor localization and margin delineation to enable maximal safe resection. Among these, intraoperative contrast-enhanced ultrasound (iCEUS) has recently been introduced into neurosurgical practice, with emerging evidence supporting its role in improving EoR. This systematic review and meta-analysis aim to evaluate the impact of iCEUS on the EoR in intracranial tumor surgery.

Methods

The literature was searched for studies on iCEUS use in intracranial tumor resection. The primary endpoints were the gross total resection (GTR) rate among iCEUS patients and its comparison with non-iCEUS patients. The secondary endpoint was the ultrasound contrast agent (UCA)-related adverse events (AEs). Subgroup analyses were performed for all gliomas and specifically for high-grade gliomas (HGG).

Results

Five studies with 193 patients, including 106 (54.1%) undergoing iCEUS-assisted resection, were analyzed. The GTR rate in iCEUS-assisted cases was 81.13% (95% CI: 70.41%–91.84%; I2 = 51%), significantly higher than in non-iCEUS cases (OR: 5.37; 95% CI: 2.41–11.97; I2 = 0%). Among patients with gliomas (all grades), the GTR rate was 76.12% (95% CI: 58.82%–93.84%; I2 = 61%), while in the HGG subgroup, it reached 79.26% (95% CI: 61.39%–97.13%; I2 = 37%). No UCA-related AEs were reported.

Conclusion

iCEUS is a valuable intraoperative imaging tool with the potential to improve GTR rates in brain tumor surgery. Further research, particularly randomized controlled trials, is needed to clarify its impact on resection and survival outcomes across tumor types and to establish its comparative effectiveness against other intraoperative imaging modalities.
鉴于优化脑肿瘤手术切除范围(EoR)的重要性,术中成像技术不断发展,增强肿瘤定位和边界划定,以实现最大限度的安全切除。其中,术中对比增强超声(iCEUS)最近被引入神经外科实践,越来越多的证据支持其在提高EoR中的作用。本系统综述和荟萃分析旨在评估iCEUS对颅内肿瘤手术EoR的影响。方法查阅相关文献,了解超声在颅内肿瘤切除术中的应用。主要终点是iCEUS患者的总切除率(GTR)及其与非iCEUS患者的比较。次要终点是超声造影剂(UCA)相关不良事件(ae)。对所有胶质瘤进行亚组分析,特别是对高级别胶质瘤(HGG)。结果我们分析了5项研究193例患者,其中106例(54.1%)接受了iceus辅助切除。iceus辅助下的GTR率为81.13% (95% CI: 70.41% ~ 91.84%; I2 = 51%),显著高于非iceus组(OR: 5.37; 95% CI: 2.41 ~ 11.97; I2 = 0%)。胶质瘤(所有级别)患者的GTR率为76.12% (95% CI: 58.82%-93.84%; I2 = 61%),而HGG亚组的GTR率为79.26% (95% CI: 61.39%-97.13%; I2 = 37%)。无uca相关ae报告。结论超声造影是一种有价值的术中成像工具,可提高脑肿瘤手术的GTR率。需要进一步的研究,特别是随机对照试验,来阐明其对不同肿瘤类型的切除和生存结果的影响,并确定其与其他术中成像方式的比较有效性。
{"title":"Intraoperative contrast-enhanced ultrasound-assisted resection of brain tumors: a systematic review and meta-analysis","authors":"Márcio Yuri Ferreira ,&nbsp;Leonardo Januário Campos Cardoso ,&nbsp;Shayan Huda ,&nbsp;Netanel Ben-Shalom","doi":"10.1016/j.neuchi.2026.101774","DOIUrl":"10.1016/j.neuchi.2026.101774","url":null,"abstract":"<div><h3>Background</h3><div>Given the critical importance of optimizing the extent of resection (EoR) in brain tumor surgery, intraoperative imaging techniques continue to evolve, enhancing tumor localization and margin delineation to enable maximal safe resection. Among these, intraoperative contrast-enhanced ultrasound (iCEUS) has recently been introduced into neurosurgical practice, with emerging evidence supporting its role in improving EoR. This systematic review and meta-analysis aim to evaluate the impact of iCEUS on the EoR in intracranial tumor surgery.</div></div><div><h3>Methods</h3><div>The literature was searched for studies on iCEUS use in intracranial tumor resection. The primary endpoints were the gross total resection (GTR) rate among iCEUS patients and its comparison with non-iCEUS patients. The secondary endpoint was the ultrasound contrast agent (UCA)-related adverse events (AEs). Subgroup analyses were performed for all gliomas and specifically for high-grade gliomas (HGG).</div></div><div><h3>Results</h3><div>Five studies with 193 patients, including 106 (54.1%) undergoing iCEUS-assisted resection, were analyzed. The GTR rate in iCEUS-assisted cases was 81.13% (95% CI: 70.41%–91.84%; I<sup>2</sup> = 51%), significantly higher than in non-iCEUS cases (OR: 5.37; 95% CI: 2.41–11.97; I<sup>2</sup> = 0%). Among patients with gliomas (all grades), the GTR rate was 76.12% (95% CI: 58.82%–93.84%; I<sup>2</sup> = 61%), while in the HGG subgroup, it reached 79.26% (95% CI: 61.39%–97.13%; I<sup>2</sup> = 37%). No UCA-related AEs were reported.</div></div><div><h3>Conclusion</h3><div>iCEUS is a valuable intraoperative imaging tool with the potential to improve GTR rates in brain tumor surgery. Further research, particularly randomized controlled trials, is needed to clarify its impact on resection and survival outcomes across tumor types and to establish its comparative effectiveness against other intraoperative imaging modalities.</div></div>","PeriodicalId":51141,"journal":{"name":"Neurochirurgie","volume":"72 2","pages":"Article 101774"},"PeriodicalIF":1.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145981248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Repeated salvage high precision radiotherapy for repeated recurrence of high-grade glioma 高级别胶质瘤反复复发的重复抢救性高精度放疗。
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-04 DOI: 10.1016/j.neuchi.2026.101784
Mami Ishikawa , Yukihiro Hama , Etsuko Tate , Masahiro Uematsu , Masaki Takahashi , Heiji Naritaka , Gen Kusaka

Background

Repeated high precision radiotherapy may be an additional salvage treatment for patients with recurrent high-grade glioma, delivering a low minimum radiation dose to brain and a high effective dose to tumor.

Materials

24 patients with high-grade gliomas (grade 3: 8 patients, grade 4: 16 patients) were treated by surgery, chemotherapy, and tomotherapy (CT-guided intensity-modulated radiotherapy (IMRT)). A total dose of 60 Gy was prescribed to PTVh (planning tumor volume h) and 40 Gy to PTV1 in 15 fractions each. PTVh and PTV1 were defined as the MRI contrast-enhanced area plus a margin and as high intensity area on the double inversion recovery images plus a margin, respectively. The planning for distant recurrence was performed as well as the first tomotherapy, and for invasive recurrence, 40 Gy or lower was prescribed to PTVh.

Results

The tomotherapy was performed for 14 of the 24 patients for the first recurrence, and for 7 of those 14 patients for the second or subsequent. Stepwise multiple regression analysis showed that patients with repeated tomotherapy had long survival time (p < 0.0001). Median survival time from the first tomotherapy (based on Kaplan-Meier estimates) was 18 months in the 14 patients with repeated tomotherapy versus 5.5 months in the 10 patients without repeated tomotherapy (p < 0.0001).

Conclusion

Repeated tomotherapy may be one of the additional salvage treatments without symptomatic adverse events for patients with repeated recurrences of glioma. Accurate and precise tomotherapy planning and neurosurgery for eloquent areas are essential for the comprehensive treatment of glioma patients.
背景:重复高精度放疗可作为复发性高级别胶质瘤患者的一种额外救助性治疗方法,其对脑的最低辐射剂量低,对肿瘤的有效剂量高。材料:对24例高级别胶质瘤患者(3级8例,4级16例)进行手术、化疗和ct引导的调强放疗(IMRT)治疗。给PTVh总剂量为60 Gy(计划肿瘤体积h),给PTV1总剂量为40 Gy,每组15次。将PTVh和PTV1分别定义为MRI增强区加边缘,将其定义为双反转恢复图像上的高强度区加边缘。在第一次放疗的同时进行远处复发的计划,对于侵袭性复发,PTVh的治疗剂量为40 Gy或更低。结果:24例首次复发患者中14例行断层治疗,14例第二次或以后复发患者中7例行断层治疗。逐步多元回归分析显示,反复ct治疗患者的生存时间较长(p)。结论:反复ct治疗可能是胶质瘤反复复发患者无症状性不良事件的补充补救性治疗之一。准确和精确的断层治疗计划和雄辩区神经外科手术对胶质瘤患者的综合治疗至关重要。
{"title":"Repeated salvage high precision radiotherapy for repeated recurrence of high-grade glioma","authors":"Mami Ishikawa ,&nbsp;Yukihiro Hama ,&nbsp;Etsuko Tate ,&nbsp;Masahiro Uematsu ,&nbsp;Masaki Takahashi ,&nbsp;Heiji Naritaka ,&nbsp;Gen Kusaka","doi":"10.1016/j.neuchi.2026.101784","DOIUrl":"10.1016/j.neuchi.2026.101784","url":null,"abstract":"<div><h3>Background</h3><div>Repeated high precision radiotherapy may be an additional salvage treatment for patients with recurrent high-grade glioma, delivering a low minimum radiation dose to brain and a high effective dose to tumor.</div></div><div><h3>Materials</h3><div>24 patients with high-grade gliomas (grade 3: 8 patients, grade 4: 16 patients) were treated by surgery, chemotherapy, and tomotherapy (CT-guided intensity-modulated radiotherapy (IMRT)). A total dose of 60 Gy was prescribed to PTVh (planning tumor volume h) and 40 Gy to PTV1 in 15 fractions each. PTVh and PTV1 were defined as the MRI contrast-enhanced area plus a margin and as high intensity area on the double inversion recovery images plus a margin, respectively. The planning for distant recurrence was performed as well as the first tomotherapy, and for invasive recurrence, 40 Gy or lower was prescribed to PTVh.</div></div><div><h3>Results</h3><div>The tomotherapy was performed for 14 of the 24 patients for the first recurrence, and for 7 of those 14 patients for the second or subsequent. Stepwise multiple regression analysis showed that patients with repeated tomotherapy had long survival time (<em>p</em> &lt; 0.0001). Median survival time from the first tomotherapy (based on Kaplan-Meier estimates) was 18 months in the 14 patients with repeated tomotherapy versus 5.5 months in the 10 patients without repeated tomotherapy (<em>p</em> &lt; 0.0001).</div></div><div><h3>Conclusion</h3><div>Repeated tomotherapy may be one of the additional salvage treatments without symptomatic adverse events for patients with repeated recurrences of glioma. Accurate and precise tomotherapy planning and neurosurgery for eloquent areas are essential for the comprehensive treatment of glioma patients.</div></div>","PeriodicalId":51141,"journal":{"name":"Neurochirurgie","volume":"72 2","pages":"Article 101784"},"PeriodicalIF":1.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146133576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modern concepts of CSF disorders in monosutural craniosynostosis 单侧颅缝闭合症脑脊液紊乱的现代概念
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-12 DOI: 10.1016/j.neuchi.2026.101773
Paolo Frassanito , Marco Galeazzi , Gianpiero Tamburrini

Introduction

Although hydrocephalus is randomly encountered in monosutural craniosynostosis (CS), CSF disorders may present more subtly and accompany these pictures. Indeed, dilation of subarachnoid spaces is frequently reported. The pathogenesis of these disorders is still under debate, as well as their prognostic significance.

Methods

A thorough review of the literature has been performed. Accordingly, pathogenic theories, eventual impact of surgical strategy, and prognostic significance are discussed.

Results

Most data come from scaphocephaly and trigonocephaly. Focal dilation of subarachnoid spaces is the most encountered CSF disorder in monosutural CS, followed by general dilation of subarachnoid spaces. Arachnoid cysts are exclusively associated to trigonocephaly. On the other side, overt hydrocephalus is a fortuitous occurrence, its pathogenesis being unrelated to monosutural CS. Pathogenesis of these CSF disorders has been related to CSF malabsorption, secondary to venous hypertension, and compensatory phenomenon. However, it is likely that local mechanisms, namely local venous hypertension and passive expansion, may better explain these pictures. Dilation of subarachnoid spaces usually resolve or at least improve after cranial remodeling and expansion. On the other side, arachnoid cysts may enlarge after fronto-orbital advancement.

Conclusions

Future study should clarify the pathogenesis of CSF disorder in monosutural CS and possibly assess the risk of raised intracranial pressure if the CS is left untreated. Furtherly, the impact on timing and surgical strategy should be carefully explored.
虽然脑积水在单缝颅缝闭闭(CS)中是随机出现的,但脑脊液疾病可能更微妙地出现并伴随这些图像。事实上,蛛网膜下腔扩张经常被报道。这些疾病的发病机制及其预后意义仍在争论中。方法对相关文献进行全面复习。因此,致病理论,最终影响的手术策略,和预后意义进行了讨论。结果大部分数据来自舟头和三角头。蛛网膜下腔的局灶性扩张是单缝CS中最常见的脑脊液紊乱,其次是蛛网膜下腔的全局性扩张。蛛网膜囊肿只与三角头有关。另一方面,明显的脑积水是偶然发生的,其发病机制与单缝合线CS无关。这些脑脊液疾病的发病机制与脑脊液吸收不良、继发于静脉高压和代偿现象有关。然而,可能是局部机制,即局部静脉高压和被动扩张,可以更好地解释这些图片。蛛网膜下腔的扩张通常在颅骨重塑和扩张后消退或至少改善。另一方面,蛛网膜囊肿可在额眶推进后扩大。结论未来的研究应阐明单缝脑脊液紊乱的发病机制,并可能评估脑脊液未经治疗后颅内压升高的风险。此外,应仔细探讨对时机和手术策略的影响。
{"title":"Modern concepts of CSF disorders in monosutural craniosynostosis","authors":"Paolo Frassanito ,&nbsp;Marco Galeazzi ,&nbsp;Gianpiero Tamburrini","doi":"10.1016/j.neuchi.2026.101773","DOIUrl":"10.1016/j.neuchi.2026.101773","url":null,"abstract":"<div><h3>Introduction</h3><div>Although hydrocephalus is randomly encountered in monosutural craniosynostosis (CS), CSF disorders may present more subtly and accompany these pictures. Indeed, dilation of subarachnoid spaces is frequently reported. The pathogenesis of these disorders is still under debate, as well as their prognostic significance.</div></div><div><h3>Methods</h3><div>A thorough review of the literature has been performed. Accordingly, pathogenic theories, eventual impact of surgical strategy, and prognostic significance are discussed.</div></div><div><h3>Results</h3><div>Most data come from scaphocephaly and trigonocephaly. Focal dilation of subarachnoid spaces is the most encountered CSF disorder in monosutural CS, followed by general dilation of subarachnoid spaces. Arachnoid cysts are exclusively associated to trigonocephaly. On the other side, overt hydrocephalus is a fortuitous occurrence, its pathogenesis being unrelated to monosutural CS. Pathogenesis of these CSF disorders has been related to CSF malabsorption, secondary to venous hypertension, and compensatory phenomenon. However, it is likely that local mechanisms, namely local venous hypertension and passive expansion, may better explain these pictures. Dilation of subarachnoid spaces usually resolve or at least improve after cranial remodeling and expansion. On the other side, arachnoid cysts may enlarge after fronto-orbital advancement.</div></div><div><h3>Conclusions</h3><div>Future study should clarify the pathogenesis of CSF disorder in monosutural CS and possibly assess the risk of raised intracranial pressure if the CS is left untreated. Furtherly, the impact on timing and surgical strategy should be carefully explored.</div></div>","PeriodicalId":51141,"journal":{"name":"Neurochirurgie","volume":"72 2","pages":"Article 101773"},"PeriodicalIF":1.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145981249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review of treatment modalities and clinical outcome of giant saccular superior cerebellar artery aneurysms 巨大囊状小脑上动脉瘤的治疗方法及临床结果综述。
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-05 DOI: 10.1016/j.neuchi.2026.101781
Andreas Theofanopoulos , Ben Waldau , Marc Ronald Schneider , Katharina Faust , Sajjad Muhammad

Introduction

Giant superior cerebellar artery (SCA) aneurysms are rare lesions with significant morbidity due to mass effect and present therapeutic challenges due to proximity to critical neurovascular structures.

Materials and methods

A systematic literature review through the PubMed and Scopus databases was performed according to the PRISMA guidelines to identify cases of giant saccular SCA aneurysms treated either microsurgically or by endovascular techniques. Patients’ demographics, aneurysm size, preoperative and postoperative neurologic status, clinical outcomes as well as follow-up information were retrieved.

Results

Data from 5 studies including 6 patients were obtained. Mean patient age was 53.83 years, with a male-to-female ratio of 2:1. Mean maximum aneurysm diameter was 31.3 mm. All patients presented at mRS 3 or more. A favorable outcome (mRS 0–2) was reported on 50% of cases. Two patients underwent microsurgery (one resulting in a favorable outcome), while two underwent endovascular treatment with both achieving a favorable outcome. Two more underwent a combination of microsurgical STA-SCA bypass followed by endovascular aneurysm treatment, both with unfavorable outcomes. All aneurysms were at least partially thrombosed; the ones treated microsurgically were debulked due to mass effect.

Conclusions

Giant SCA aneurysms may cause severe, often persistent neurologic morbidity due to brainstem compression and may be approached by either microsurgery or endovascular treatment. Advanced endovascular techniques may be required to prevent recurrence. Thrombosed aneurysms which cannot be safely embolized or ones with significant mass effect may benefit from microsurgical clip occlusion and may require debulking, while hybrid techniques should be used judiciously.
简介:巨大的小脑上动脉(SCA)动脉瘤是一种罕见的病变,由于肿块效应,发病率很高,并且由于靠近关键的神经血管结构,给治疗带来了挑战。材料和方法:根据PRISMA指南,通过PubMed和Scopus数据库进行系统的文献综述,以确定采用显微手术或血管内技术治疗的巨大囊状SCA动脉瘤病例。检索患者的人口统计学、动脉瘤大小、术前和术后神经系统状况、临床结果以及随访信息。结果:获得5项研究资料,包括6例患者。患者平均年龄53.83岁,男女比例为2:1。平均最大动脉瘤直径为31.3 mm。所有患者的mRS均为3或以上。50%的病例预后良好(mRS 0-2)。2例患者接受显微手术(1例结果良好),2例患者接受血管内治疗,均获得良好结果。另外两名患者接受了显微外科STA-SCA搭桥术,随后进行了血管内动脉瘤治疗,结果均不理想。所有动脉瘤至少部分形成血栓;经显微外科手术治疗的患者因肿块效应而出现肿大。结论:由于脑干压迫,巨大的SCA动脉瘤可引起严重的、经常持续的神经系统疾病,可通过显微手术或血管内治疗来治疗。可能需要先进的血管内技术来防止复发。不能安全栓塞的血栓性动脉瘤或有明显肿块效应的动脉瘤可通过显微手术夹闭塞并可能需要减体积,而混合技术应谨慎使用。
{"title":"Review of treatment modalities and clinical outcome of giant saccular superior cerebellar artery aneurysms","authors":"Andreas Theofanopoulos ,&nbsp;Ben Waldau ,&nbsp;Marc Ronald Schneider ,&nbsp;Katharina Faust ,&nbsp;Sajjad Muhammad","doi":"10.1016/j.neuchi.2026.101781","DOIUrl":"10.1016/j.neuchi.2026.101781","url":null,"abstract":"<div><h3>Introduction</h3><div>Giant superior cerebellar artery (SCA) aneurysms are rare lesions with significant morbidity due to mass effect and present therapeutic challenges due to proximity to critical neurovascular structures.</div></div><div><h3>Materials and methods</h3><div>A systematic literature review through the PubMed and Scopus databases was performed according to the PRISMA guidelines to identify cases of giant saccular SCA aneurysms treated either microsurgically or by endovascular techniques. Patients’ demographics, aneurysm size, preoperative and postoperative neurologic status, clinical outcomes as well as follow-up information were retrieved.</div></div><div><h3>Results</h3><div>Data from 5 studies including 6 patients were obtained. Mean patient age was 53.83 years, with a male-to-female ratio of 2:1. Mean maximum aneurysm diameter was 31.3 mm. All patients presented at mRS 3 or more. A favorable outcome (mRS 0–2) was reported on 50% of cases. Two patients underwent microsurgery (one resulting in a favorable outcome), while two underwent endovascular treatment with both achieving a favorable outcome. Two more underwent a combination of microsurgical STA-SCA bypass followed by endovascular aneurysm treatment, both with unfavorable outcomes. All aneurysms were at least partially thrombosed; the ones treated microsurgically were debulked due to mass effect.</div></div><div><h3>Conclusions</h3><div>Giant SCA aneurysms may cause severe, often persistent neurologic morbidity due to brainstem compression and may be approached by either microsurgery or endovascular treatment. Advanced endovascular techniques may be required to prevent recurrence. Thrombosed aneurysms which cannot be safely embolized or ones with significant mass effect may benefit from microsurgical clip occlusion and may require debulking, while hybrid techniques should be used judiciously.</div></div>","PeriodicalId":51141,"journal":{"name":"Neurochirurgie","volume":"72 2","pages":"Article 101781"},"PeriodicalIF":1.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146133557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The neurosurgeon as athlete, gentleman, and physician: Thierry de Martel (1875–1940) as a model for contemporary practice 作为运动员、绅士和内科医生的神经外科医生:蒂埃里·德·马特尔(1875-1940)是当代实践的典范
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-16 DOI: 10.1016/j.neuchi.2026.101772
Johan Pallud
{"title":"The neurosurgeon as athlete, gentleman, and physician: Thierry de Martel (1875–1940) as a model for contemporary practice","authors":"Johan Pallud","doi":"10.1016/j.neuchi.2026.101772","DOIUrl":"10.1016/j.neuchi.2026.101772","url":null,"abstract":"","PeriodicalId":51141,"journal":{"name":"Neurochirurgie","volume":"72 2","pages":"Article 101772"},"PeriodicalIF":1.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145981247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polyethylene glycol-coated patch versus standard dural sealing practices for preventing cerebrospinal fluid leaks in posterior fossa surgery: a randomized multicenter study 聚乙二醇包覆贴片与标准硬脑膜密封方法预防后颅窝手术脑脊液泄漏:一项随机多中心研究
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-28 DOI: 10.1016/j.neuchi.2026.101777
Alberto Acitores Cancela , María Pérez Pérez , Luis González Martínez , Jorge Díaz Molina , Laura Beatriz López López , Sofía Sotos Picazo , Carmen Tudela Ataz , Cristina Barcelo López , Juan Carlos Rial Básalo , Cristina Ferreras , Belén Álvarez , Adán Fernández Canal , Jose Manuel Ortega , Jorge Bernal Piñeiro , Yaiza López Ramírez , Carlos Alberto Rodríguez Arias , Rubén Martín Laez , Patricia López Gómez , Luís Ley-Urzaiz

Background

This study evaluated the efficacy and safety of the polyethylene glycol (PEG)-coated patch as a dural sealant in elective non-traumatic posterior fossa surgeries (nTPFS) requiring dural closure.

Methods

This multicenter, randomized, controlled phase-IV study was conducted, between January and December 2022, on adult patients who underwent nTPFS requiring dural opening and closure. Patients were randomized to receive either PEG-coated patch reinforcement or standard sealing. The primary endpoint was the incidence of clinically evident cerebrospinal fluid (CSF)-leakage within four weeks post-intervention.

Results

A total of 121 patients were included, 57(47.1%) in the PEG-coated patch group and 64(52.9%) in the standard sealing group. No statistically significant differences were observed in the primary endpoint of clinically evident CSF leak (12.3% vs. 9.4%; incidence rate difference: 2.9%; 95%CI: –8.7% to 14.6%; p = 0.606). Secondary outcomes were also comparable between groups, including pseudomeningocele (24.6% vs. 20.3%; p = 0.575), hospital readmissions (12.3% vs. 9.4%; p = 0.606), surgical site infections (5.3% vs. 4.7%; p = 0.884), and adverse events (22.8% vs. 20.3%; p = 0.739). Two patients, one in each group, experienced serious adverse events classified as “hospitalization or prolonged stay.” Most adverse events were mild to moderate and resolved with standard medical management.

Conclusions

The PEG-coated patch, alone or with fibrin sealant, demonstrated comparable efficacy in preventing CSF leak compared to multiple product combinations. The study does not demonstrate superiority, but shows a reassuring safety profile and similar rates of secondary outcomes, including pseudomeningocele, hospital readmissions, surgical site infections and adverse events, in both groups. These findings support the PEG-coated patch as a safe dural sealing option in elective non-traumatic posterior fossa surgery, while potential workflow or economic advantages remain to be formally evaluated in future studies.
背景:本研究评估了聚乙二醇(PEG)涂层贴片作为硬脑膜密封剂在选择性非创伤性后窝手术(nTPFS)中需要硬脑膜闭合的有效性和安全性。方法:这项多中心、随机、对照的iv期研究于2022年1月至12月进行,研究对象是接受nTPFS手术、需要打开和关闭硬脑膜的成年患者。患者随机接受peg涂层贴片加固或标准密封。主要终点是干预后四周内临床明显脑脊液(CSF)渗漏的发生率。结果:共纳入121例患者,peg包被贴片组57例(47.1%),标准封口组64例(52.9%)。临床明显脑脊液漏的主要终点差异无统计学意义(12.3% vs. 9.4%;发生率差异为2.9%;95%CI: -8.7% ~ 14.6%; p = 0.606)。两组间的次要结局也具有可比性,包括假性脑膜膨出(24.6%比20.3%,p = 0.575)、再入院(12.3%比9.4%,p = 0.606)、手术部位感染(5.3%比4.7%,p = 0.884)和不良事件(22.8%比20.3%,p = 0.739)。两名患者,每组一名,经历了严重的不良事件,被分类为“住院或长期住院”。大多数不良事件为轻至中度,并通过标准的医疗管理得到解决。结论:与多种产品组合相比,peg包被贴片单独使用或与纤维蛋白密封剂联合使用,在预防脑脊液泄漏方面显示出相当的疗效。该研究没有显示出优势,但显示了令人放心的安全性和相似的次要结局发生率,包括假性脑膜炎,再入院,手术部位感染和不良事件,两组。这些研究结果支持peg包覆贴片作为选择性非创伤性后窝手术中安全的硬脑膜密封选择,但潜在的工作流程或经济优势仍需在未来的研究中进行正式评估。
{"title":"Polyethylene glycol-coated patch versus standard dural sealing practices for preventing cerebrospinal fluid leaks in posterior fossa surgery: a randomized multicenter study","authors":"Alberto Acitores Cancela ,&nbsp;María Pérez Pérez ,&nbsp;Luis González Martínez ,&nbsp;Jorge Díaz Molina ,&nbsp;Laura Beatriz López López ,&nbsp;Sofía Sotos Picazo ,&nbsp;Carmen Tudela Ataz ,&nbsp;Cristina Barcelo López ,&nbsp;Juan Carlos Rial Básalo ,&nbsp;Cristina Ferreras ,&nbsp;Belén Álvarez ,&nbsp;Adán Fernández Canal ,&nbsp;Jose Manuel Ortega ,&nbsp;Jorge Bernal Piñeiro ,&nbsp;Yaiza López Ramírez ,&nbsp;Carlos Alberto Rodríguez Arias ,&nbsp;Rubén Martín Laez ,&nbsp;Patricia López Gómez ,&nbsp;Luís Ley-Urzaiz","doi":"10.1016/j.neuchi.2026.101777","DOIUrl":"10.1016/j.neuchi.2026.101777","url":null,"abstract":"<div><h3>Background</h3><div>This study evaluated the efficacy and safety of the polyethylene glycol (PEG)-coated patch as a dural sealant in elective non-traumatic posterior fossa surgeries (nTPFS) requiring dural closure.</div></div><div><h3>Methods</h3><div>This multicenter, randomized, controlled phase-IV study was conducted, between January and December 2022, on adult patients who underwent nTPFS requiring dural opening and closure. Patients were randomized to receive either PEG-coated patch reinforcement or standard sealing. The primary endpoint was the incidence of clinically evident cerebrospinal fluid (CSF)-leakage within four weeks post-intervention.</div></div><div><h3>Results</h3><div>A total of 121 patients were included, 57(47.1%) in the PEG-coated patch group and 64(52.9%) in the standard sealing group. No statistically significant differences were observed in the primary endpoint of clinically evident CSF leak (12.3% vs. 9.4%; incidence rate difference: 2.9%; 95%CI: –8.7% to 14.6%; p = 0.606). Secondary outcomes were also comparable between groups, including pseudomeningocele (24.6% vs. 20.3%; p = 0.575), hospital readmissions (12.3% vs. 9.4%; p = 0.606), surgical site infections (5.3% vs. 4.7%; p = 0.884), and adverse events (22.8% vs. 20.3%; p = 0.739). Two patients, one in each group, experienced serious adverse events classified as “hospitalization or prolonged stay.” Most adverse events were mild to moderate and resolved with standard medical management.</div></div><div><h3>Conclusions</h3><div>The PEG-coated patch, alone or with fibrin sealant, demonstrated comparable efficacy in preventing CSF leak compared to multiple product combinations. The study does not demonstrate superiority, but shows a reassuring safety profile and similar rates of secondary outcomes, including pseudomeningocele, hospital readmissions, surgical site infections and adverse events, in both groups. These findings support the PEG-coated patch as a safe dural sealing option in elective non-traumatic posterior fossa surgery, while potential workflow or economic advantages remain to be formally evaluated in future studies.</div></div>","PeriodicalId":51141,"journal":{"name":"Neurochirurgie","volume":"72 2","pages":"Article 101777"},"PeriodicalIF":1.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146087900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The longest documented survival after cranial trepanation in the Renaissance: The thirteen years’ exceptional survival in Vespasiano Gonzaga Colonna 文艺复兴时期颅骨钻孔后最长的存活记录:Vespasiano Gonzaga Colonna的13年异常存活
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2026-03-01 Epub Date: 2026-03-09 DOI: 10.1016/j.neuchi.2026.101790
Annalisa Pace , Cecilia Carubbi , Luigi Cofone , Marco Vitale , Mauro Palmieri , Ivano Pindinello , Yaroslava Longhitano , Marco Artico
This essay focuses on the Vespasiano Gonzaga Colonna (1531–1591), a remarkable example of long-term life following cranial trepanation during the Renaissance. Gonzaga suffered from syphilis and frequent migraines; therefore, in 1578, his court surgeon used a scraping procedure to perform cranial trepanation. The right parietal bone had obvious indications of healing, and osteological data from his tomb validated the surgery. One of the longest reported survivors following cranial trepanation in the Italian archaeological record, Gonzaga, lived for 13 years after the treatment. This instance adds to the historical understanding of trepanation as one of the earliest neurosurgical procedures, and demonstrates the high degree of surgical expertise attained in early modern noble courts.
这篇文章的重点是Vespasiano Gonzaga Colonna(1531-1591),文艺复兴时期颅骨穿孔后长期生活的一个显著例子。冈萨加患有梅毒和频繁的偏头痛;因此,在1578年,他的宫廷外科医生使用刮痧手术进行颅骨钻孔。右顶骨有明显的愈合迹象,从他的坟墓中获得的骨学数据证实了手术的有效性。据报道,意大利考古记录中颅骨钻孔后最长的幸存者之一冈萨加在治疗后活了13年。这个例子增加了对钻孔作为最早的神经外科手术之一的历史理解,并展示了早期现代贵族宫廷获得的高度外科专业知识。
{"title":"The longest documented survival after cranial trepanation in the Renaissance: The thirteen years’ exceptional survival in Vespasiano Gonzaga Colonna","authors":"Annalisa Pace ,&nbsp;Cecilia Carubbi ,&nbsp;Luigi Cofone ,&nbsp;Marco Vitale ,&nbsp;Mauro Palmieri ,&nbsp;Ivano Pindinello ,&nbsp;Yaroslava Longhitano ,&nbsp;Marco Artico","doi":"10.1016/j.neuchi.2026.101790","DOIUrl":"10.1016/j.neuchi.2026.101790","url":null,"abstract":"<div><div>This essay focuses on the Vespasiano Gonzaga Colonna (1531–1591), a remarkable example of long-term life following cranial trepanation during the Renaissance. Gonzaga suffered from syphilis and frequent migraines; therefore, in 1578, his court surgeon used a scraping procedure to perform cranial trepanation. The right parietal bone had obvious indications of healing, and osteological data from his tomb validated the surgery. One of the longest reported survivors following cranial trepanation in the Italian archaeological record, Gonzaga, lived for 13 years after the treatment. This instance adds to the historical understanding of trepanation as one of the earliest neurosurgical procedures, and demonstrates the high degree of surgical expertise attained in early modern noble courts.</div></div>","PeriodicalId":51141,"journal":{"name":"Neurochirurgie","volume":"72 2","pages":"Article 101790"},"PeriodicalIF":1.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147421641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fatal pneumocephalus caused by Clostridium perfringens bacteremia originating from emphysematous cystitis after stroke-related blood–brain barrier disruption 脑卒中相关血脑屏障破坏后,由气肿性膀胱炎引起的产气荚膜梭菌菌血症引起的致死性气脑。
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-24 DOI: 10.1016/j.neuchi.2026.101788
Cyril Pernod , Baptiste Quilly , Philippe Lavrard , Hilaire de Malleray , Johan Schmitt , Nathan Beucler
Infectious pneumocephalus is rare and usually associated with meningitis or neurosurgical procedures. We report a fatal case of diffuse pneumocephalus caused by Clostridium perfringens bacteremia originating from emphysematous cystitis in a patient recently admitted for a large right middle cerebral artery infarction. Imaging demonstrated subarachnoid gas strictly confined to the infarcted hemisphere, followed by subdural air accumulation and fatal mass effect. We hypothesize that stroke-related blood–brain barrier disruption permitted hematogenous bacterial and gas diffusion into the subarachnoid space. This case highlights the distinction between negative-pressure postoperative pneumocephalus and positive-pressure infectious pneumocephalus in a closed skull.
感染性气脑是罕见的,通常与脑膜炎或神经外科手术有关。我们报告一例由产气荚膜梭状芽胞杆菌菌血症引起的弥漫性气脑致死病例,起因于肺气肿性膀胱炎。影像学显示蛛网膜下腔气体严格局限于梗死半球,随后是硬膜下空气积聚和致命的肿块效应。我们假设中风相关的血脑屏障破坏允许血源性细菌和气体扩散到蛛网膜下腔。本病例强调了术后负压气头和封闭颅骨正压感染性气头的区别。
{"title":"Fatal pneumocephalus caused by Clostridium perfringens bacteremia originating from emphysematous cystitis after stroke-related blood–brain barrier disruption","authors":"Cyril Pernod ,&nbsp;Baptiste Quilly ,&nbsp;Philippe Lavrard ,&nbsp;Hilaire de Malleray ,&nbsp;Johan Schmitt ,&nbsp;Nathan Beucler","doi":"10.1016/j.neuchi.2026.101788","DOIUrl":"10.1016/j.neuchi.2026.101788","url":null,"abstract":"<div><div>Infectious pneumocephalus is rare and usually associated with meningitis or neurosurgical procedures. We report a fatal case of diffuse pneumocephalus caused by <em>Clostridium perfringens</em> bacteremia originating from emphysematous cystitis in a patient recently admitted for a large right middle cerebral artery infarction. Imaging demonstrated subarachnoid gas strictly confined to the infarcted hemisphere, followed by subdural air accumulation and fatal mass effect. We hypothesize that stroke-related blood–brain barrier disruption permitted hematogenous bacterial and gas diffusion into the subarachnoid space. This case highlights the distinction between negative-pressure postoperative pneumocephalus and positive-pressure infectious pneumocephalus in a closed skull.</div></div>","PeriodicalId":51141,"journal":{"name":"Neurochirurgie","volume":"72 2","pages":"Article 101788"},"PeriodicalIF":1.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147312365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Neurochirurgie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1